Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.613 USD | -0.66% | -5.68% | +12.13% |
05-09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
05-09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.13% | 37.08M | |
+38.69% | 728B | |
+33.06% | 603B | |
-5.32% | 360B | |
+19.72% | 332B | |
+1.48% | 279B | |
+16.15% | 244B | |
+7.89% | 207B | |
-5.81% | 205B | |
+5.82% | 164B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : VYNE Therapeutics Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 02